logo

Coherus Biosciences Inc’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects

PNC Stock

Coherus Biosciences Inc ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $8.65 on 04/17/23, while the lowest value for the same period was recorded at $1.43 on 11/10/23.

52-week price history of CHRS Stock

A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Coherus Biosciences Inc’s current trading price is -72.14% away from its 52-week high, while its distance from the 52-week low is 68.52%. The stock’s price range during this period has spanned from $1.43 to $8.65. In the Healthcare sector, the Coherus Biosciences Inc’s shares surpassed a trading volume of approximately 1.76 million for the day, which was noticeably lower compared to the average daily volume of 9.3.55 million over the past three months.

Market Capitalization and Financial Performance: An In-Depth Look

Coherus Biosciences Inc (CHRS) has experienced a quarterly decline of -15.73% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 268.38M and boasts a workforce of 306 employees.

Making Sense of Trading Volume and Moving Average Data

Based on Barchart.com data, the company’s moving average over the 100-day period was 2.38, with a change in price of +0.61. Similarly, Coherus Biosciences Inc recorded 4,889,299 in trading volume during the last 100 days, posting a change of +33.89%.

CHRS Stock Stochastic Average

Today’s raw stochastic average for Coherus Biosciences Inc over the last 50 days is 51.32%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 61.02%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 66.67% and 70.06%, respectively.

CHRS Stock Price Performance Analysis

Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. Year to date metric has recorded a loss of -27.63%.However, over the last six months, we can see a stronger performance of -36.66%. Over the last 30 days, the price of CHRS has fallen by 7.59%. And in the last five days, it has surged by 3.43%.